Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Open Badges Research news

Natural calcineurin inhibitor

Jonathan B Weitzman

Genome Biology 2003, 4:spotlight-20030103-01  doi:10.1186/gb-spotlight-20030103-01

The electronic version of this article is the complete one and can be found online at:

Published:3 January 2003

© 2003 BioMed Central Ltd

Research news

FK506 is an immunosuppressive drug that inhibits the phosphatase activity of calcineurin, thereby interfering with normal signal transduction pathways. In an Advanced Online Publication in Nature Cell Biology Shirane and Nakayama from Kyushu University in Japan, describe a role for the mitochondrial FK506-binding protein 38 (FKBP38) in preventing apoptosis (Nature Cell Biology, 23 December 2002, DOI:10.1038/ncb894). They fished out FKBP38 in a yeast two-hybrid screen for Bcl-2-interacting proteins. FKBP38 co-immunoprecipitates with Bcl-2 and the related Bcl-XL protein. It also interacts with calcineurin, in a FK506-independent manner, and inhibits its phosphatase activity. FKBP38 regulates the cellular localization of Bcl-2 and Bcl-XL, targeting them to the mitochondria and preventing apoptosis.


  1. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [] webcite

    Nature Cell Biology

  3. [] webcite

    Kyushu University

  4. Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs.

    PubMed Abstract | Publisher Full Text OpenURL